OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide
MarketLine, March 2012, Pages: 140
OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the Top 5 Emerging markets (Brazil, China, India, Mexico and South Africa). The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.
Scope of the Report
- Contains an executive summary and data on value, volume and segmentation
- Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
- Incorporates in-depth five forces competitive environment analysis and scorecards
- Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country. .
- Includes a five-year forecast of the industry
Highlights
The top 5 emerging countries contributed $19,690.4 million to the global OTC pharmaceuticals industry in 2010, with a compound annual growth rate (CAGR) of 6.5% between 2007 and 2011.
The top 5 emerging countries are expected to reach a value of $26,137.8 million in 2015, with a CAGR of 5.8% over the 2010–15 period.
Within the OTC pharmaceuticals industry, China is the leading country among the top 5 emerging nations, with market revenues of $10,582.8 million in 2010.
The China is expected to lead the OTC pharmaceuticals industry in the top five emerging nations, with a value of $14,378.8 million in 2015.
Why you should buy this report
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
Market Definition
The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2010 annual average exchange rates.
TABLE OF CONTENTS
Introduction 11
What is this report about? 11
Who is the target reader? 11
How to use this report 11
Definitions 11
Top 5 Emerging Countries OTC Pharmaceuticals Industy Outlook 12
OTC Pharmaceuticals in South Africa 15
Market Overview 15
Market Data 16
Market Segmentation 17
Market outlook 22
Five forces analysis 23
Leading companies 29
Macroeconomic indicators 34
OTC Pharmaceuticals in Brazil 36
Market Overview 36
Market Data 37
Market Segmentation 38
Market outlook 43
Five forces analysis 44
Leading companies 50
Macroeconomic indicators 60
OTC Pharmaceuticals in China 62
Market Overview 62
Market Data 63
Market Segmentation 64
Market outlook 69
Five forces analysis 70
Leading companies 76
Macroeconomic indicators 82
OTC Pharmaceuticals in India 84
Market Overview 84
Market Data 85
Market Segmentation 86
Market outlook 91
Five forces analysis 92
Leading companies 98
Macroeconomic indicators 109
OTC Pharmaceuticals in Mexico 111
Market Overview 111
Market Data 112
Market Segmentation 113
Market outlook 118
Five forces analysis 119
Leading companies 125
Macroeconomic indicators 137
Appendix 139
Methodology 139
LIST OF TABLES
Table 1:Top 5 emerging countries OTC pharmaceuticals industry, revenue ($m), 2006–15 12
Table 2:Top 5 emerging countries OTC pharmaceuticals industry, revenue ($m), 2006–10 13
Table 3:Top 5 emerging countries OTC pharmaceuticals industry forecast, revenue ($m), 2010–15 14
Table 4: South Africa OTC pharmaceuticals market value: $ million, 2006–10 16
Table 5: South Africa OTC pharmaceuticals market category segmentation: % share, by value, 2006–2010 17
Table 6: South Africa OTC pharmaceuticals market category segmentation: $ million, 2006-2010 17
Table 7: South Africa OTC pharmaceuticals market geography segmentation: $million, 2010 19
Table 8: South Africa OTC pharmaceuticals market share: % share, by value, 2010 20
Table 9: South Africa OTC pharmaceuticals market distribution: % share, by value, 2010 21
Table 10: South Africa OTC pharmaceuticals market value forecast: $ million, 2010–15 22
Table 11: Pharma Natura (Pty) Ltd: key facts 29
Table 12: Weleda Group: key facts 30
Table 13: GlaxoSmithKline Plc: key facts 31
Table 14: GlaxoSmithKline Plc: key financials ($) 32
Table 15: GlaxoSmithKline Plc: key financials (£) 32
Table 16: GlaxoSmithKline Plc: key financial ratios 32
Table 17: South Africa size of population (million), 2006–10 34
Table 18: South Africa gdp (constant 2000 prices, $ billion), 2006–10 34
Table 19: South Africa gdp (current prices, $ billion), 2006–10 34
Table 20: South Africa inflation, 2006–10 35
Table 21: South Africa consumer price index (absolute), 2006–10 35
Table 22: South Africa exchange rate, 2006–10 35
Table 23: Brazil OTC pharmaceuticals market value: $ million, 2006–10 37
Table 24: Brazil OTC pharmaceuticals market category segmentation: % share, by value, 2006–2010 38
Table 25: Brazil OTC pharmaceuticals market category segmentation: $ million, 2006-2010 38
Table 26: Brazil OTC pharmaceuticals market geography segmentation: $million, 2010 40
Table 27: Brazil OTC pharmaceuticals market share: % share, by value, 2010 41
Table 28: Brazil OTC pharmaceuticals market distribution: % share, by value, 2010 42
Table 29: Brazil OTC pharmaceuticals market value forecast: $ million, 2010–15 43
Table 30: Johnson & Johnson: key facts 50
Table 31: Johnson & Johnson: key financials ($) 51
Table 32: Johnson & Johnson: key financial ratios 52
Table 33: Sanofi-Aventis SA: key facts 54
Table 34: Sanofi-Aventis SA: key financials ($) 55
Table 35: Sanofi-Aventis SA: key financials (€) 55
Table 36: Sanofi-Aventis SA: key financial ratios 55
Table 37: Abbott Laboratories: key facts 57
Table 38: Abbott Laboratories: key financials ($) 58
Table 39: Abbott Laboratories: key financial ratios 58
Table 40: Brazil size of population (million), 2006–10 60
Table 41: Brazil gdp (constant 2000 prices, $ billion), 2006–10 60
Table 42: Brazil gdp (current prices, $ billion), 2006–10 60
Table 43: Brazil inflation, 2006–10 61
Table 44: Brazil consumer price index (absolute), 2006–10 61
Table 45: Brazil exchange rate, 2006–10 61
Table 46: China OTC pharmaceuticals market value: $ million, 2006–10 63
Table 47: China OTC pharmaceuticals market category segmentation: % share, by value, 2006–2010 64
Table 48: China OTC pharmaceuticals market category segmentation: $ million, 2006-2010 64
Table 49: China OTC pharmaceuticals market geography segmentation: $million, 2010 66
Table 50: China OTC pharmaceuticals market share: % share, by value, 2010 67
Table 51: China OTC pharmaceuticals market distribution: % share, by value, 2010 68
Table 52: China OTC pharmaceuticals market value forecast: $ million, 2010–15 69
Table 53: Johnson & Johnson: key facts 76
Table 54: Johnson & Johnson: key financials ($) 77
Table 55: Johnson & Johnson: key financial ratios 78
Table 56: Chengdu Rosun Antiseptic Pharmaceutical Co., Ltd.: key facts 80
Table 57: Huangshan Tianmu Pharmaceutical Co., Ltd.: key facts 81
Table 58: China size of population (million), 2006–10 82
Table 59: China gdp (constant 2000 prices, $ billion), 2006–10 82
Table 60: China gdp (current prices, $ billion), 2006–10 82
Table 61: China inflation, 2006–10 83
Table 62: China consumer price index (absolute), 2006–10 83
Table 63: China exchange rate, 2006–10 83
Table 64: India OTC pharmaceuticals market value: $ million, 2006–10 85
Table 65: India OTC pharmaceuticals market category segmentation: % share, by value, 2006–2010 86
Table 66: India OTC pharmaceuticals market category segmentation: $ million, 2006-2010 86
Table 67: India OTC pharmaceuticals market geography segmentation: $million, 2010 88
Table 68: India OTC pharmaceuticals market share: % share, by value, 2010 89
Table 69: India OTC pharmaceuticals market distribution: % share, by value, 2010 90
Table 70: India OTC pharmaceuticals market value forecast: $ million, 2010–15 91
Table 71: Cipla Ltd: key facts 98
Table 72: Cipla Ltd: key financials ($) 99
Table 73: Cipla Ltd: key financials (Rs.) 100
Table 74: Cipla Ltd: key financial ratios 100
Table 75: Johnson & Johnson: key facts 102
Table 76: Johnson & Johnson: key financials ($) 103
Table 77: Johnson & Johnson: key financial ratios 104
Table 78: GlaxoSmithKline Plc: key facts 106
Table 79: GlaxoSmithKline Plc: key financials ($) 107
Table 80: GlaxoSmithKline Plc: key financials (£) 107
Table 81: GlaxoSmithKline Plc: key financial ratios 107
Table 82: India size of population (million), 2006–10 109
Table 83: India gdp (constant 2000 prices, $ billion), 2006–10 109
Table 84: India gdp (current prices, $ billion), 2006–10 109
Table 85: India inflation, 2006–10 110
Table 86: India consumer price index (absolute), 2006–10 110
Table 87: India exchange rate, 2006–10 110
Table 88: Mexico OTC pharmaceuticals market value: $ million, 2006–10 112
Table 89: Mexico OTC pharmaceuticals market category segmentation: % share, by value, 2006–2010 113
Table 90: Mexico OTC pharmaceuticals market category segmentation: $ million, 2006-2010 113
Table 91: Mexico OTC pharmaceuticals market geography segmentation: $million, 2010 115
Table 92: Mexico OTC pharmaceuticals market share: % share, by value, 2010 116
Table 93: Mexico OTC pharmaceuticals market distribution: % share, by value, 2010 117
Table 94: Mexico OTC pharmaceuticals market value forecast: $ million, 2010–15 118
Table 95: Bayer AG: key facts 125
Table 96: Bayer AG: key financials ($) 126
Table 97: Bayer AG: key financials (€) 126
Table 98: Bayer AG: key financial ratios 127
Table 99: Johnson & Johnson: key facts 129
Table 100: Johnson & Johnson: key financials ($) 130
Table 101: Johnson & Johnson: key financial ratios 131
Table 102: Boehringer Ingelheim GmbH: key facts 133
Table 103: Boehringer Ingelheim GmbH: key financials ($) 134
Table 104: Boehringer Ingelheim GmbH: key financials (€) 134
Table 105: Boehringer Ingelheim GmbH: key financial ratios 135
Table 106: Mexico size of population (million), 2006–10 137
Table 107: Mexico gdp (constant 2000 prices, $ billion), 2006–10 137
Table 108: Mexico gdp (current prices, $ billion), 2006–10 137
Table 109: Mexico inflation, 2006–10 138
Table 110: Mexico consumer price index (absolute), 2006–10 138
Table 111: Mexico exchange rate, 2006–10 138
LIST OF FIGURES
Figure 1: Top 5 emerging countries OTC pharmaceuticals industry, revenue ($m), 2006–15 12
Figure 2: Top 5 emerging countries OTC pharmaceuticals industry, revenue ($m), 2006–10 13
Figure 3: Top 5 emerging countries OTC pharmaceuticals industry forecast, revenue ($m), 2010–15 14
Figure 4: South Africa OTC pharmaceuticals market value: $ million, 2006–10 16
Figure 5: South Africa OTC pharmaceuticals market category segmentation: $ million, 2006-2010 18
Figure 6: South Africa OTC pharmaceuticals market geography segmentation: % share, by value, 2010 19
Figure 7: South Africa OTC pharmaceuticals market share: % share, by value, 2010 20
Figure 8: South Africa OTC pharmaceuticals market distribution: % share, by value, 2010 21
Figure 9: South Africa OTC pharmaceuticals market value forecast: $ million, 2010–15 22
Figure 10: Forces driving competition in the OTC pharmaceuticals market in South Africa, 2010 23
Figure 11: Drivers of buyer power in the OTC pharmaceuticals market in South Africa, 2010 24
Figure 12: Drivers of supplier power in the OTC pharmaceuticals market in South Africa, 2010 25
Figure 13: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in South Africa, 2010 26
Figure 14: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in South Africa, 2010 27
Figure 15: Drivers of degree of rivalry in the OTC pharmaceuticals market in South Africa, 2010 28
Figure 16: GlaxoSmithKline Plc: revenues & profitability 33
Figure 17: GlaxoSmithKline Plc: assets & liabilities 33
Figure 18: Brazil OTC pharmaceuticals market value: $ million, 2006–10 37
Figure 19: Brazil OTC pharmaceuticals market category segmentation: $ million, 2006-2010 39
Figure 20: Brazil OTC pharmaceuticals market geography segmentation: % share, by value, 2010 40
Figure 21: Brazil OTC pharmaceuticals market share: % share, by value, 2010 41
Figure 22: Brazil OTC pharmaceuticals market distribution: % share, by value, 2010 42
Figure 23: Brazil OTC pharmaceuticals market value forecast: $ million, 2010–15 43
Figure 24: Forces driving competition in the OTC pharmaceuticals market in Brazil, 2010 44
Figure 25: Drivers of buyer power in the OTC pharmaceuticals market in Brazil, 2010 45
Figure 26: Drivers of supplier power in the OTC pharmaceuticals market in Brazil, 2010 46
Figure 27: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Brazil, 2010 47
Figure 28: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Brazil, 2010 48
Figure 29: Drivers of degree of rivalry in the OTC pharmaceuticals market in Brazil, 2010 49
Figure 30: Johnson & Johnson: revenues & profitability 52
Figure 31: Johnson & Johnson: assets & liabilities 53
Figure 32: Sanofi-Aventis SA: revenues & profitability 56
Figure 33: Sanofi-Aventis SA: assets & liabilities 56
Figure 34: Abbott Laboratories: revenues & profitability 59
Figure 35: Abbott Laboratories: assets & liabilities 59
Figure 36: China OTC pharmaceuticals market value: $ million, 2006–10 63
Figure 37: China OTC pharmaceuticals market category segmentation: $ million, 2006-2010 65
Figure 38: China OTC pharmaceuticals market geography segmentation: % share, by value, 2010 66
Figure 39: China OTC pharmaceuticals market share: % share, by value, 2010 67
Figure 40: China OTC pharmaceuticals market distribution: % share, by value, 2010 68
Figure 41: China OTC pharmaceuticals market value forecast: $ million, 2010–15 69
Figure 42: Forces driving competition in the OTC pharmaceuticals market in China, 2010 70
Figure 43: Drivers of buyer power in the OTC pharmaceuticals market in China, 2010 71
Figure 44: Drivers of supplier power in the OTC pharmaceuticals market in China, 2010 72
Figure 45: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in China, 2010 73
Figure 46: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in China, 2010 74
Figure 47: Drivers of degree of rivalry in the OTC pharmaceuticals market in China, 2010 75
Figure 48: Johnson & Johnson: revenues & profitability 78
Figure 49: Johnson & Johnson: assets & liabilities 79
Figure 50: India OTC pharmaceuticals market value: $ million, 2006–10 85
Figure 51: India OTC pharmaceuticals market category segmentation: $ million, 2006-2010 87
Figure 52: India OTC pharmaceuticals market geography segmentation: % share, by value, 2010 88
Figure 53: India OTC pharmaceuticals market share: % share, by value, 2010 89
Figure 54: India OTC pharmaceuticals market distribution: % share, by value, 2010 90
Figure 55: India OTC pharmaceuticals market value forecast: $ million, 2010–15 91
Figure 56: Forces driving competition in the OTC pharmaceuticals market in India, 2010 92
Figure 57: Drivers of buyer power in the OTC pharmaceuticals market in India, 2010 93
Figure 58: Drivers of supplier power in the OTC pharmaceuticals market in India, 2010 94
Figure 59: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in India, 2010 95
Figure 60: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in India, 2010 96
Figure 61: Drivers of degree of rivalry in the OTC pharmaceuticals market in India, 2010 97
Figure 62: Cipla Ltd: revenues & profitability 100
Figure 63: Cipla Ltd: assets & liabilities 101
Figure 64: Johnson & Johnson: revenues & profitability 104
Figure 65: Johnson & Johnson: assets & liabilities 105
Figure 66: GlaxoSmithKline Plc: revenues & profitability 108
Figure 67: GlaxoSmithKline Plc: assets & liabilities 108
Figure 68: Mexico OTC pharmaceuticals market value: $ million, 2006–10 112
Figure 69: Mexico OTC pharmaceuticals market category segmentation: $ million, 2006-2010 114
Figure 70: Mexico OTC pharmaceuticals market geography segmentation: % share, by value, 2010 115
Figure 71: Mexico OTC pharmaceuticals market share: % share, by value, 2010 116
Figure 72: Mexico OTC pharmaceuticals market distribution: % share, by value, 2010 117
Figure 73: Mexico OTC pharmaceuticals market value forecast: $ million, 2010–15 118
Figure 74: Forces driving competition in the OTC pharmaceuticals market in Mexico, 2010 119
Figure 75: Drivers of buyer power in the OTC pharmaceuticals market in Mexico, 2010 120
Figure 76: Drivers of supplier power in the OTC pharmaceuticals market in Mexico, 2010 121
Figure 77: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Mexico, 2010 122
Figure 78: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Mexico, 2010 123
Figure 79: Drivers of degree of rivalry in the OTC pharmaceuticals market in Mexico, 2010 124
Figure 80: Bayer AG: revenues & profitability 127
Figure 81: Bayer AG: assets & liabilities 128
Figure 82: Johnson & Johnson: revenues & profitability 131
Figure 83: Johnson & Johnson: assets & liabilities 132
Figure 84: Boehringer Ingelheim GmbH: revenues & profitability 135
Figure 85: Boehringer Ingelheim GmbH: assets & liabilities 136
Customers who bought this item also bought
All rights reserved. © Copyright 2013 Research and Markets WWW4
Terms and Conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network
